Harmony Biosciences Holdings Inc (HRMY) Stock Price, Quote & News

Company Profile

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also develops Pitolisant that is in Phase 3 clinical trial for the treatment of Prader-Willi Syndrome (PWS); in Phase 2 c...

Industry: Biotechnology

Sector: Healthcare

Phone: 484 539 9800

Website: www.harmonybiosciences.com

Address:

630 West Germantown Pike, Suite 215, Plymouth Meeting, United States

StockHunter75 Oct. 6 at 2:30 PM

$HRMY bullish

0 · Reply

OnlyFibs Oct. 5 at 2:27 AM

$HRMY- Harmony Bio - Bullish - I am betting on this new higher low aka also low of year lol - Bulls need to claim $27.77 and we can rip #hovdid

1 · Reply

LottiedeKitchen Oct. 4 at 5:46 AM

CVKD Exciting news: Cadrenal Therapeutics Company Webcast @ Lytham Partners Fall 2025 Investor Conference. Watch live here: https://youtu.be/NfPbBjgeIbg?si=2xPvJ2_YJQjHipGa $HRMY $RKT $PLTR $ACHR $BROS

0 · Reply

trading_signal Oct. 4 at 4:55 AM

I didn't alert it, but after the short term drop to end the week I dipped my toes with 1 contract $HRMY

0 · Reply

trading_insight Oct. 4 at 4:55 AM

$BUD - Beer is generally recession proof and Anheuser-Busch is cheap right now vs historical values. I think there's a Call LEAP trade there Jan/15/2027 75c $HRMY as a high risk call swing from the lows also looks enticing Nov/21 30c

0 · Reply

StockHunter75 Oct. 1 at 8:19 PM

$HRMY Bullish

0 · Reply

BigDaddyCapital Oct. 1 at 4:43 PM

$HRMY probably one of the best value plays in healthcare

0 · Reply

Investinator5000 Oct. 1 at 3:49 PM

$HRMY Great Entry 👌 Started position

0 · Reply

G0dofshad0w Oct. 1 at 3:11 PM

$HRMY P/E is 6.79! Ridiculously low for a VERY profitable company

0 · Reply

G0dofshad0w Oct. 1 at 3:03 PM

$HRMY Oversold now the upside potential is great. 35$ price target minimum. The average consensus is 45$. Max is 61 $

0 · Reply

Top 3 Health Care Stocks That Are Preparing To Pump In Q4

CRVL MLTX

Sep 24, 2025, 2:18 PM EDT - 12 days ago

Freeport-McMoRan, Harmony Biosciences, Cohu, And Other Big Stocks Moving Lower On Wednesday

COHU FCX

Sep 24, 2025, 8:33 AM EDT - 12 days ago

Harmony Biosciences' genetic disorder drug fails to meet main goal in late-stage trial

Sep 24, 2025, 8:00 AM EDT - 12 days ago

Harmony Biosciences Provides Update From Its Phase 3 RECONNECT Study of ZYN002 in Fragile X Syndrome

Sep 15, 2025, 2:18 PM EDT - 21 days ago

11 fast-growing small-cap stocks that could get a boost from the Fed's next move

AGYS ASTH CORT ENVA GSHD HASI KNTK

Sep 5, 2025, 1:09 AM EDT - 4 weeks ago

Harmony Biosciences Holdings, Inc. (HRMY) Presents at Cantor Global Healthcare Conference 2025 Transcript

Aug 26, 2025, 8:05 AM EDT - 5 weeks ago

Harmony Biosciences to Present Rare Epilepsy Data at the 36th International Epilepsy Congress

Aug 21, 2025, 8:05 AM EDT - 6 weeks ago

Harmony Biosciences to Participate in 2025 Cantor Global Healthcare Conference

Aug 20, 2025, 4:15 PM EDT - 6 weeks ago

Harmony Biosciences: Reiterating Buy Ahead Of Data Catalyst For Cannabinoid Drug

Aug 5, 2025, 4:04 PM EDT - 2 months ago

Harmony Biosciences Holdings, Inc. (HRMY) Q2 2025 Earnings Call Transcript

Aug 5, 2025, 7:30 AM EDT - 2 months ago

Harmony Biosciences Reports Strong Q2 2025 Financial Results and Reaffirms 2025 Revenue Guidance; On Track to Announce Fragile X Topline Data From Phase 3 Registrational Trial in Q3 2025

Jul 22, 2025, 8:05 AM EDT - 2 months ago

Harmony Biosciences to Report Second Quarter 2025 Financial Results on August 5, 2025

Jul 15, 2025, 8:05 AM EDT - 2 months ago

Harmony Biosciences to Participate in H.C. Wainwright "HCW@Home" Series

Jun 11, 2025, 8:05 AM EDT - 4 months ago

Harmony Biosciences Presents Preclinical Data Demonstrating Significant Wake-Promoting and Cataplexy-Suppressing Effects of BP1.15205 in Narcolepsy at SLEEP 2025

Jun 5, 2025, 8:05 AM EDT - 4 months ago

Harmony Biosciences Strengthens Patent Position With Favorable Settlement in ANDA Litigation

Jun 4, 2025, 8:05 AM EDT - 4 months ago

Harmony Biosciences to Participate in Goldman Sachs 46th Annual Global Healthcare Conference

May 6, 2025, 5:05 PM EDT - 5 months ago

Harmony Biosciences Holdings, Inc. (HRMY) Q1 2025 Earnings Call Transcript

May 6, 2025, 7:30 AM EDT - 5 months ago

Harmony Biosciences Reports Strong Q1 2025 Financial Results, Highlights Advancement of Its Pipeline and Upcoming Catalysts, and Reaffirms 2025 Revenue Guidance

Apr 29, 2025, 8:05 AM EDT - 5 months ago

Harmony Biosciences to Report First Quarter 2025 Financial Results on May 6, 2025

Apr 8, 2025, 10:00 AM EDT - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Harmony Biosciences Holdings, Inc. (HRMY) And Encourages Shareholders to Connect

Apr 8, 2025, 8:05 AM EDT - 6 months ago

Harmony Biosciences Presents Promising Open-Label Extension Data of ZYN002 in Fragile X Syndrome

Apr 7, 2025, 10:00 AM EDT - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Harmony Biosciences Holdings, Inc. (HRMY) And Encourages Shareholders to Reach Out

Apr 6, 2025, 10:00 AM EDT - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Harmony Biosciences Holdings, Inc. (HRMY) and Encourages Shareholders to Learn More About the Investigation

Apr 4, 2025, 10:00 AM EDT - 6 months ago

Harmony Biosciences Holdings, Inc. (HRMY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Apr 3, 2025, 10:00 AM EDT - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Harmony Biosciences Holdings, Inc. (HRMY) and Encourages Investors to Learn More About the Investigation

Apr 3, 2025, 8:05 AM EDT - 6 months ago

Harmony Biosciences Appoints Biotech Leader Ron Philip to Its Board of Directors

Apr 2, 2025, 10:00 AM EDT - 6 months ago

Harmony Biosciences Holdings, Inc. (HRMY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Apr 1, 2025, 10:00 AM EDT - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Harmony Biosciences Holdings, Inc. (HRMY) And Encourages Investors to Connect

Mar 31, 2025, 10:00 AM EDT - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Harmony Biosciences Holdings, Inc. (HRMY) Stockholders to Inquire about Securities Investigation

Mar 28, 2025, 10:00 AM EDT - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Harmony Biosciences Holdings, Inc. (HRMY) And Encourages Stockholders to Connect

Mar 27, 2025, 10:00 AM EDT - 6 months ago

Harmony Biosciences Holdings, Inc. (HRMY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Mar 26, 2025, 10:00 AM EDT - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Harmony Biosciences Holdings, Inc. (HRMY) and Encourages Stockholders to Learn More About the Investigation

Mar 26, 2025, 8:05 AM EDT - 6 months ago

Harmony Biosciences to Participate in 24th Annual Needham Virtual Healthcare Conference

Mar 25, 2025, 10:00 AM EDT - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Harmony Biosciences Holdings, Inc. (HRMY) Investors to Inquire about Securities Investigation

Mar 24, 2025, 2:00 PM EDT - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Harmony Biosciences Holdings, Inc. (HRMY) And Encourages Investors to Reach Out

Mar 24, 2025, 12:09 PM EDT - 7 months ago

Harmony Biosciences: A Compelling Risk-Reward Opportunity

Mar 24, 2025, 8:05 AM EDT - 7 months ago

Harmony Biosciences Names Adam Zaeske as Chief Commercial Officer to Lead the Next Phase of Commercial Growth as Its Portfolio Expands

Mar 21, 2025, 7:45 PM EDT - 7 months ago

HRMY Investors Have Opportunity to Join Harmony Biosciences Holdings, Inc. Fraud Investigation with the Schall Law Firm

Mar 4, 2025, 8:05 AM EST - 7 months ago

Harmony Biosciences to Participate in Upcoming Investor Conferences

Feb 25, 2025, 3:05 PM EST - 7 months ago

Harmony Biosciences Holdings, Inc. (HRMY) Q4 2024 Earnings Call Transcript

Feb 25, 2025, 7:30 AM EST - 7 months ago

Harmony Biosciences Reports Strong 2024 Financial Results and Reiterates 2025 Net Revenue Guidance; Highlights 2025 Catalysts in Sleep/Wake and Fragile X Syndrome Development Programs

Feb 19, 2025, 2:24 PM EST - 8 months ago

Harmony Biosciences Stock Falls On FDA Setback For Pitolisant In Sleeping Disorder

Feb 19, 2025, 8:05 AM EST - 8 months ago

Harmony Biosciences Provides Update on the Status of the Supplemental New Drug Application for Pitolisant in Idiopathic Hypersomnia

Feb 18, 2025, 8:05 AM EST - 8 months ago

Harmony Biosciences to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025

Jan 24, 2025, 1:05 PM EST - 9 months ago

Harmony Biosciences: Don't Sleep On This Enterprising, Profitable Biotech

Jan 13, 2025, 8:05 AM EST - 9 months ago

Harmony Biosciences Reports Strong 2024 Revenues, Provides 2025 Revenue Guidance and Highlights Key Pipeline Catalysts

Dec 18, 2024, 8:05 AM EST - 10 months ago

HARMONY BIOSCIENCES TO PRESENT AT THE 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

StockHunter75 Oct. 6 at 2:30 PM

$HRMY bullish

0 · Reply

OnlyFibs Oct. 5 at 2:27 AM

$HRMY- Harmony Bio - Bullish - I am betting on this new higher low aka also low of year lol - Bulls need to claim $27.77 and we can rip #hovdid

1 · Reply

LottiedeKitchen Oct. 4 at 5:46 AM

0 · Reply

trading_signal Oct. 4 at 4:55 AM

I didn't alert it, but after the short term drop to end the week I dipped my toes with 1 contract $HRMY

0 · Reply

trading_insight Oct. 4 at 4:55 AM

0 · Reply

StockHunter75 Oct. 1 at 8:19 PM

$HRMY Bullish

0 · Reply

BigDaddyCapital Oct. 1 at 4:43 PM

$HRMY probably one of the best value plays in healthcare

0 · Reply

Investinator5000 Oct. 1 at 3:49 PM

$HRMY Great Entry 👌 Started position

0 · Reply

G0dofshad0w Oct. 1 at 3:11 PM

$HRMY P/E is 6.79! Ridiculously low for a VERY profitable company

0 · Reply

G0dofshad0w Oct. 1 at 3:03 PM

$HRMY Oversold now the upside potential is great. 35$ price target minimum. The average consensus is 45$. Max is 61 $

0 · Reply

Invest2live Oct. 1 at 2:43 PM

$B 102% already; congrats 🎊 🎉🎈 Checkout $NGD and $HRMY As well as $CUE

0 · Reply

AlarmedSheiky Oct. 1 at 2:32 PM

$HRMY Wow

0 · Reply

Broview Sep. 28 at 11:18 PM

$HRMY pay dividend please

1 · Reply

Mr_Charlie Sep. 25 at 7:18 PM

$HRMY I had some hope of getting the money back invested in Zynerba. Hopes gone now.

1 · Reply

anachartanalyst Sep. 25 at 6:02 PM

$HRMY https://anachart.com/wp-content/uploads/ana_temp/1758823337_soc-img.jpg

0 · Reply

ZacksResearch Sep. 25 at 5:09 PM

$HRMY plummets 16.56% — RECONNECT study disappointment hits hard! 😬 The late-stage trial for ZYN002 in Fragile X syndrome missed its primary endpoint, mainly due to a higher-than-expected placebo response rate. This blow comes as HRMY struggles with a 22.2% YTD decline, despite the industry gaining 5.3%. Discover what’s next for HRMY’s pipeline and potential turnaround 👉 https://www.zacks.com/stock/news/2757080/hrmy-stock-down-as-fragile-x-syndrome-study-fails-to-meet-goal?cid=sm-stocktwits-2-2757080-body-14170&ADID=SYND_STOCKTWITS_TWEET_2_2757080_BODY_14170

0 · Reply

ZacksResearch Sep. 25 at 4:09 PM

$HRMY tanks on trial failure — but is the pipeline still strong? ZYN002 missed in Fragile X, sparking a sharp selloff, yet Wakix sales and fresh epilepsy assets are keeping growth prospects alive. Full bull/bear breakdown here 👉 https://www.zacks.com/stock/news/2757080/hrmy-stock-down-as-fragile-x-syndrome-study-fails-to-meet-goal?cid=sm-stocktwits-2-2757080-teaser-14169&ADID=SYND_STOCKTWITS_TWEET_2_2757080_TEASER_14169

0 · Reply

anachartanalyst Sep. 25 at 4:02 PM

$HRMY https://anachart.com/wp-content/uploads/ana_temp/1758816125_soc-img.jpg

0 · Reply

JarvisFlow Sep. 25 at 1:28 PM

Deutsche Bank has adjusted their stance on Harmony Biosciences Hldgs ( $HRMY ), setting the rating to Buy with a target price of 54 → 36.

0 · Reply

JarvisFlow Sep. 25 at 12:25 PM

HC Wainwright & Co. updates rating for Harmony Biosciences Hldgs ( $HRMY ) to Buy, target set at 70 → 55.

0 · Reply

Okadarlan Sep. 24 at 9:58 PM

$HRMY forgot i was short, thanks for the cash.

0 · Reply

outlawinvestor1 Sep. 24 at 9:06 PM

$HRMY

0 · Reply

Market Cap	1.57B
Revenue (ttm)	714.73M
Net Income (ttm)	145.49M
EPS (ttm)	N/A
PE Ratio	8.63
Forward PE	8.50
Profit Margin	20.36%
Debt to Equity Ratio	0.22

Volume	768,700
Avg Vol	788,920
Day's Range	N/A - N/A
Shares Out	57.53M
Stochastic %K	8%
Beta	0.79
Analysts	Strong Sell
Price Target	$44.55